Antiviral drug Remdesivir has been cleared

REMDESIVIR CLEARED

• Antiviral drug Remdesivir has been cleared for treatment of COVID-19 patients “under emergency use”
• Remdesivir: It is a broad-spectrum antiviral medication
• As of 2020, remdesivir is being tested as a specific treatment for COVID-19
• Authorized for emergency use in the US, India, and approved for use in Japan for people with severe symptoms.
• It may shorten the time it takes to recover from the infection
• Remdesivir was originally created and developed by Gilead Sciences in 2009
• Remdesivir was originally developed to treat hepatitis C and was then tested against Ebola virus disease and Marburg virus disease
• Side effects may include liver inflammation and an infusion-related reaction with nausea, low blood pressure, and sweating.
• Remdesivir is the international nonproprietary name (INN) while the development code name was GS-5734